Literature DB >> 33338412

PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19.

Min-Seok Rha1, Hye Won Jeong2, Jae-Hoon Ko3, Seong Jin Choi1, In-Ho Seo1, Jeong Seok Lee4, Moa Sa5, A Reum Kim1, Eun-Jeong Joo6, Jin Young Ahn7, Jung Ho Kim7, Kyoung-Ho Song8, Eu Suk Kim8, Dong Hyun Oh9, Mi Young Ahn9, Hee Kyoung Choi10, Ji Hoon Jeon10, Jae-Phil Choi9, Hong Bin Kim8, Young Keun Kim11, Su-Hyung Park5, Won Suk Choi12, Jun Yong Choi13, Kyong Ran Peck14, Eui-Cheol Shin15.   

Abstract

Memory T cell responses have been demonstrated in COVID-19 convalescents, but ex vivo phenotypes of SARS-CoV-2-specific T cells have been unclear. We detected SARS-CoV-2-specific CD8+ T cells by MHC class I multimer staining and examined their phenotypes and functions in acute and convalescent COVID-19. Multimer+ cells exhibited early differentiated effector-memory phenotypes in the early convalescent phase. The frequency of stem-like memory cells was increased among multimer+ cells in the late convalescent phase. Cytokine secretion assays combined with MHC class I multimer staining revealed that the proportion of interferon-γ (IFN-γ)-producing cells was significantly lower among SARS-CoV-2-specific CD8+ T cells than those specific to influenza A virus. Importantly, the proportion of IFN-γ-producing cells was higher in PD-1+ cells than PD-1- cells among multimer+ cells, indicating that PD-1-expressing, SARS-CoV-2-specific CD8+ T cells are not exhausted, but functional. Our current findings provide information for understanding of SARS-CoV-2-specific CD8+ T cells elicited by infection or vaccination.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD8(+) T cell; COVID-19; IFN-γ; MHC class I multimer; Memory T cell; PD-1; SARS-CoV-2

Year:  2020        PMID: 33338412     DOI: 10.1016/j.immuni.2020.12.002

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  70 in total

1.  SARS-CoV-2, COVID-19 and the Ageing Immune System.

Authors:  Juliet M Bartleson; Dina Radenkovic; Anthony J Covarrubias; David Furman; Daniel A Winer; Eric Verdin
Journal:  Nat Aging       Date:  2021-09-14

2.  Protracted yet Coordinated Differentiation of Long-Lived SARS-CoV-2-Specific CD8+ T Cells during Convalescence.

Authors:  Tongcui Ma; Heeju Ryu; Matthew McGregor; Benjamin Babcock; Jason Neidleman; Guorui Xie; Ashley F George; Julie Frouard; Victoria Murray; Gurjot Gill; Eliver Ghosn; Evan W Newell; Sulggi A Lee; Nadia R Roan
Journal:  J Immunol       Date:  2021-08-13       Impact factor: 5.422

3.  Peripheral and lung resident memory T cell responses against SARS-CoV-2.

Authors:  Judith Grau-Expósito; Nerea Sánchez-Gaona; Núria Massana; Marina Suppi; Antonio Astorga-Gamaza; David Perea; Joel Rosado; Anna Falcó; Cristina Kirkegaard; Ariadna Torrella; Bibiana Planas; Jordi Navarro; Paula Suanzes; Daniel Álvarez-Sierra; Alfonso Ayora; Irene Sansano; Juliana Esperalba; Cristina Andrés; Andrés Antón; Santiago Ramón Y Cajal; Benito Almirante; Ricardo Pujol-Borrell; Vicenç Falcó; Joaquín Burgos; María J Buzón; Meritxell Genescà
Journal:  Nat Commun       Date:  2021-05-21       Impact factor: 14.919

4.  SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8+ T cell activation in COVID-19 patients.

Authors:  Ditte Stampe Hersby; Tripti Tamhane; Sunil Kumar Saini; Helle Rus Povlsen; Susana Patricia Amaya Hernandez; Morten Nielsen; Anne Ortved Gang; Sine Reker Hadrup
Journal:  Sci Immunol       Date:  2021-04-14

5.  Critical COVID-19 is associated with distinct leukocyte phenotypes and transcriptome patterns.

Authors:  E E Christensen; M J Jørgensen; K G Nore; T B Dahl; K Yang; T Ranheim; C Huse; A Lind; S Nur; B Stiksrud; S Jenum; K Tonby; J C Holter; A R Holten; B Halvorsen; A M Dyrhol-Riise
Journal:  J Intern Med       Date:  2021-06-03       Impact factor: 13.068

6.  The Immunopathobiology of SARS-CoV-2 Infection.

Authors:  Milankumar Patel; Farah Shahjin; Jacob D Cohen; Mahmudul Hasan; Jatin Machhi; Heerak Chugh; Snigdha Singh; Srijanee Das; Tanmay A Kulkarni; Jonathan Herskovitz; Douglas D Meigs; Ramesh Chandra; Kenneth S Hettie; R Lee Mosley; Bhavesh D Kevadiya; Howard E Gendelman
Journal:  FEMS Microbiol Rev       Date:  2021-11-23       Impact factor: 16.408

7.  Landscape of epitopes targeted by T cells in 852 individuals recovered from COVID-19: Meta-analysis, immunoprevalence, and web platform.

Authors:  Ahmed Abdul Quadeer; Syed Faraz Ahmed; Matthew R McKay
Journal:  Cell Rep Med       Date:  2021-05-21

Review 8.  Delivery Routes for COVID-19 Vaccines.

Authors:  Jang Hyun Park; Heung Kyu Lee
Journal:  Vaccines (Basel)       Date:  2021-05-19

9.  Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19.

Authors:  Jason Neidleman; Xiaoyu Luo; Ashley F George; Matthew McGregor; Junkai Yang; Cassandra Yun; Victoria Murray; Gurjot Gill; Warner C Greene; Joshua Vasquez; Sulggi A Lee; Eliver Ghosn; Kara L Lynch; Nadia R Roan
Journal:  Cell Rep       Date:  2021-06-29       Impact factor: 9.423

10.  Rapid, simplified whole blood-based multiparameter assay to quantify and phenotype SARS-CoV-2-specific T-cells.

Authors:  Catherine Riou; Georgia Schäfer; Elsa du Bruyn; Rene T Goliath; Cari Stek; Huihui Mou; Deli Hung; Katalin A Wilkinson; Robert J Wilkinson
Journal:  Eur Respir J       Date:  2022-01-13       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.